Sathianathen N - Search Results

1

Novel agents for metastatic hormone-sensitive prostate cancer - a practice guide for urologists.

Thangasamy IA, Kwan EM, Teh J, Sathianathen N, Alghazo O, Siva S, Azad A, Murphy DG. Thangasamy IA, et al. Among authors: sathianathen n. BJU Int. 2020 Mar;125(3):342-345. doi: 10.1111/bju.14936. Epub 2019 Nov 15. BJU Int. 2020. PMID: 31660679 No abstract available.

2

A Systematic Review of Intra- and Postoperative Complication Reporting and Grading in Urological Surgery: Understanding the Pitfalls and a Path Forward.

Soliman C, Sathianathen NJ, Thomas BC, Giannarini G, Lawrentschuk N, Wuethrich PY, Dundee P, Nair R, Furrer MA. Soliman C, et al. Among authors: sathianathen nj. Eur Urol Oncol. 2023 Aug;6(4):378-389. doi: 10.1016/j.euo.2023.01.002. Epub 2023 Jan 23. Eur Urol Oncol. 2023. PMID: 36697322 Review.

3

Outcomes of artificial urinary sphincter implantation in the irradiated patient.

Sathianathen NJ, McGuigan SM, Moon DA. Sathianathen NJ, et al. BJU Int. 2014 Apr;113(4):636-41. doi: 10.1111/bju.12518. Epub 2014 Feb 14. BJU Int. 2014. PMID: 24131859

4

Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.

Basto M, Sathianathen N, Te Marvelde L, Ryan S, Goad J, Lawrentschuk N, Costello AJ, Moon DA, Heriot AG, Butler J, Murphy DG. Basto M, et al. Among authors: sathianathen n. BJU Int. 2016 Jun;117(6):930-9. doi: 10.1111/bju.13317. Epub 2015 Oct 1. BJU Int. 2016. PMID: 26350758

5

Gleason pattern 4: active surveillance no more.

Sathianathen NJ, Murphy DG, van den Bergh RC, Lawrentschuk N. Sathianathen NJ, et al. BJU Int. 2016 Jun;117(6):856-7. doi: 10.1111/bju.13333. Epub 2015 Oct 29. BJU Int. 2016. PMID: 26390094 No abstract available.

6

'ProtecTion' from overtreatment: does a randomized trial finally answer the key question in localized prostate cancer?

Wang LL, Wallis CJ, Sathianathen N, Lawrentschuk N, Murphy DG, Nam R, Moon D. Wang LL, et al. Among authors: sathianathen n. BJU Int. 2017 Apr;119(4):513-514. doi: 10.1111/bju.13734. Epub 2017 Jan 4. BJU Int. 2017. PMID: 27930856 No abstract available.

7

Updates of prostate cancer staging: Prostate-specific membrane antigen.

Sathianathen NJ, Lamb A, Nair R, Geurts N, Mitchell C, Lawrentschuk NL, Moon DA, Murphy DG. Sathianathen NJ, et al. Investig Clin Urol. 2016 Dec;57(Suppl 2):S147-S154. doi: 10.4111/icu.2016.57.S2.S147. Epub 2016 Nov 30. Investig Clin Urol. 2016. PMID: 27995218 Free PMC article. Review.

8

The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory.

Sathianathen NJ, Geurts N, Nair R, Lawrentschuk N, Murphy DG, Lamb AD. Sathianathen NJ, et al. Future Oncol. 2017 Aug;13(20):1801-1807. doi: 10.2217/fon-2017-0074. Epub 2017 Aug 1. Future Oncol. 2017. PMID: 28762288 Review.

9

Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years.

Sathianathen NJ, Lamb AD, Lawrentschuk NL, Goad JR, Peters J, Costello AJ, Murphy DG, Moon DA. Sathianathen NJ, et al. ANZ J Surg. 2018 Mar;88(3):E200-E203. doi: 10.1111/ans.14169. Epub 2017 Sep 18. ANZ J Surg. 2018. PMID: 28922689

10

Magnetic resonance imaging cognitive fusion biopsy - is near enough good enough?

Sathianathen NJ, Christidis D, Konety BR, Lawrentschuk NL. Sathianathen NJ, et al. BJU Int. 2018 Mar;121(3):324-326. doi: 10.1111/bju.14103. Epub 2018 Jan 3. BJU Int. 2018. PMID: 29237233 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters